OCA
RXDX
Octagon Capital Advisors’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-15,000
| Closed | -$1.65M | – | 44 |
|
|
2022
Q4 | $1.65M | Buy |
+15,000
| New | +$1.65M | 0.26% | 28 |
|
|
2022
Q3 | – | Sell |
-80,000
| Closed | -$2.26M | – | 40 |
|
|
2022
Q2 | $2.26M | Hold |
80,000
| – | – | 0.6% | 17 |
|
|
2022
Q1 | $3.02M | Sell |
80,000
-120,000
| -60% | -$4.53M | 0.65% | 21 |
|
|
2021
Q4 | $7.91M | Hold |
200,000
| – | – | 1.54% | 16 |
|
|
2021
Q3 | $4.74M | Hold |
200,000
| – | – | 1.17% | 19 |
|
|
2021
Q2 | $4.91M | Hold |
200,000
| – | – | 1.02% | 25 |
|
|
2021
Q1 | $3.65M | Buy |
+200,000
| New | +$3.65M | 1.38% | 26 |
|